Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 8692052
Genetically modified mice and engraftment
granted -
US 8691511
Hydroxylated 1,2,4-oxadiazole benzoic acid compounds, compositions thereof and their use in bioassays
granted -
US 8691501
Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis
granted -
US 8691768
Methods of determining delta opioid receptor subtypes
granted -
US 8691796
Pharmaceutical composition and method for inhibiting inflammation
granted -
US 8691778
Flurbiprofen and muscle relaxant gel combinations thereof
granted -
US 8691195
Peptide having activity of transforming growth factor and production method therefor
granted -
US 8691204
Synthetic diblock copolypeptide hydrogels for use in the central nervous system
granted -
US 8691786
Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
granted -
US 8691522
Composition comprising extracellular membrane vesicles derived from indoor air, and use thereof
granted -
AU 2012308663
Formulations of cyclopropanecarboxylic acid {2-[1S)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amidecelgene corporation state of incorporation:delaware
granted -
US 8685404
Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction
granted -
US 8685926
Compositions and method for CaMKII inhibitors and uses thereof
granted -
US 8685932
Targeted transforming growth factor-beta-bound IgG for Treatment of Diseases
granted -
US 8686041
Inhibition of ornithine aminotransferase for the treatment of proliferative disorders
granted -
US 8685979
Oligomer-diarylpiperazine conjugates
granted -
US 8686012
Stem cell differentiating agents and uses therefor
granted -
US 8685936
Sphingosine kinase inhibitor prodrugs
granted -
US 8685973
Pyrimidine cyclohexyl glucocorticoid receptor modulators
granted -
US 8686010
Aryl- or heteroaryl-sulfonyl compounds as acid secretion inhibitors
granted -
US 8686016
Schweinfurthins and uses thereof
granted -
US 8686045
Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotrophin mimetics
granted -
US 8686157
Processes for the facile synthesis of diaryl amines and analogues thereof
granted -
US 8686143
Compounds useful as inhibitors of Janus kinases
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.